The health-care industry's biggest conference just finished up, and the Fool's health-care team was keeping close watch. While much of the interest was focused on biotech outfits big and small, the industry's titans, the big pharmaceutical companies, made some noise of their own.
Our health-care bureau chief, Brenton Flynn, listened in on seven big pharmaceutical companies that made an appearance, and in the following video he outlines one of the major therapeutic areas of focus: diabetes.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.